Patient satisfaction and adverse response from prevention with 240mg galcanezumab of episodic cluster headache

被引：0
作者：
Mo, H. [1 ]
Kim, B. K. [2 ]
Moon, H. S. [3 ]
Cho, S. J. [1 ]
机构：
[1] Hallym Univ, Dongtan Sacred Heart Hosp, Neurol, Hwaseong Si, Gyeonggi Do, South Korea
[2] Eulji Univ, Nowon Eulji Med Ctr, Neurol, Seoul, South Korea
[3] Kangbuk Samsung Hosp, Neurol, Seoul, South Korea
来源：
CEPHALALGIA | 2021年 / 41卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0157
引用
收藏
页码：100 / 101
页数：2
相关论文
共 30 条
[1]   Patient satisfaction and adverse response from prevention with 240mg galcanezumab of episodic cluster headache [J].
Mo, H. ;
Kim, B. K. ;
Moon, H. S. ;
Cho, S. J. .
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1) :67-67
[2]   Trial of Galcanezumab in Prevention of Episodic Cluster Headache [J].
Goadsby, Peter J. ;
Dodick, David W. ;
Leone, Massimo ;
Bardos, Jennifer N. ;
Oakes, Tina M. ;
Millen, Brian A. ;
Zhou, Chunmei ;
Dowsett, Sherie A. ;
Aurora, Sheena K. ;
Ahn, Andrew H. ;
Yang, Jyun-Yan ;
Conley, Robert R. ;
Martinez, James M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02) :132-141
[3]   Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache [J].
Lesley J. Scott .
Drugs, 2020, 80 :893-904
[4]   Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache [J].
Scott, Lesley J. .
DRUGS, 2020, 80 (09) :893-904
[5]   Correction to: Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache [J].
Lesley J. Scott .
Drugs, 2020, 80 :1379-1379
[6]   Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache [J].
Mo, Heejung ;
Kim, Byung-Kun ;
Moon, Heui-Soo ;
Cho, Soo-Jin .
JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01)
[7]   Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache [J].
Heejung Mo ;
Byung-Kun Kim ;
Heui-Soo Moon ;
Soo-Jin Cho .
The Journal of Headache and Pain, 2022, 23
[8]   Galcanezumab: A Review in the Prevention of Migraine and Treatment of Episodic Cluster Headache (vol 80, pg 893, 2020) [J].
Scott, Lesley J. .
DRUGS, 2020, 80 (13) :1379-1379
[9]   Efficacy Results from an Open-Label Safety Study of Galcanezumab in Patients with Episodic or Chronic Cluster Headache [J].
Gaul, C. ;
Riesenberg, R. ;
Stroud, C. ;
Dong, Y. ;
Oakes, T. Myers .
CEPHALALGIA, 2021, 41 (1_SUPPL) :234-235
[10]   Efficacy Results from an Open-Label Safety Study of Galcanezumab in Patients with Episodic or Chronic Cluster Headache [J].
Gaul, C. ;
Riesenberg, R. ;
Stroud, C. ;
Dong, Y. ;
Oakes, T. Myers .
JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 2)
123